- Home
- AMED
AMED
Amedisys Inc
as 04-01-2025 4:00pm EST
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | BATON ROUGE |
| Market Cap: | 3.0B | IPO Year: | N/A |
| Target Price: | $101.00 | AVG Volume (30 days): | 313.5K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $82.15 - $98.95 | Next Earning Date: | 04-23-2025 |
| Revenue: | $2,348,324,000 | Revenue Growth: | 5.00% |
| Revenue Growth (this year): | 6.54% | Revenue Growth (next year): | 5.32% |
Stock Insider Trading Activity of Amedisys Inc (AMED)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Guidroz Allyson | AMED | Chief Accounting Officer | Mar 4 '25 | Sell | $92.03 | 2,041 | $187,833.23 | 8,761 |
Latest Amedisys Inc News
AMED Breaking Stock News: Dive into AMED Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report?
Zacks
13 days ago
Here's Why You Should Retain AMED Stock in Your Portfolio Now
Argus Research
a month ago
AMED: Raising target price to $97.00
Zacks
a month ago
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
Zacks
a month ago
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks
a month ago
Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates
Associated Press Finance
a month ago
Amedisys: Q4 Earnings Snapshot
GlobeNewswire
a month ago
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
Compare AMED vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMED Amedisys Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.